Back to company

BIOLIT ApS: Financial statements 2024

CVR: 10068460

BIOLIT ApS (CVR 10068460) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 60,205 and a net result of DKK 13,041,006 compared with DKK 4,787,957 the year before. That is a decrease of 93.8% compared with the year before. Equity amounted to DKK 31,379,243. The solvency ratio was 68.2%.

Gross Profit
60,205 kr.
Profit/Loss
13,041,006 kr.
Equity
31,379,243 kr.
Total Assets
46,027,486 kr.
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-60 t.13 mio.31.4 mio.0
2023-974 t.4.8 mio.18.3 mio.0
2022-2.4 mio.3.2 mio.13.6 mio.0
2021-1.8 mio.1.6 mio.10.4 mio.0
2020-1.5 mio.1.7 mio.8.8 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is BIOLIT ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2024

Thomas Velin joins the board of BIOLIT ApSSep 27, 2024

As of September 27, 2024, Thomas Velin has joined the board of directors of BIOLIT ApS.

Niels Ebbe Valdal leaves the board of BIOLIT ApSSep 27, 2024

As of September 27, 2024, Niels Ebbe Valdal has left the board of directors of BIOLIT ApS.

Thomas Velin leaves the board of BIOLIT ApSSep 26, 2024

As of September 26, 2024, Thomas Velin has left the board of directors of BIOLIT ApS.

About BIOLIT ApS

BIOLIT ApS is a Danish company of the type Anpartsselskab based in Fredensborg, founded in 2001. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Flemming Velin. The company is owned by SCANVET ANIMAL HEALTH A/S. The company has 3 employees. In 2025, the company reported a gross profit of DKK 125,902 and a net result of DKK -20,616,619 compared with DKK 13,041,006 the year before. Equity amounted to DKK 10,762,624.